Inhibition of poly-LacNAc biosynthesis with release of CMP-Neu5Ac feedback inhibition increases the sialylation of recombinant EPO produced in CHO cells

Abstract Sialylation of recombinant therapeutic glycoproteins modulates their pharmacokinetic properties by affecting their in vivo half-life. N-glycan branching on glycoproteins increases the number of potential attachment sites for sialic acid. Here, we introduce a new approach for increasing the...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chung-Geun Lee, Myung Jin Oh, Seung-Yeol Park, Hyun Joo An, Jung Hoe Kim
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
R
Q
Acceso en línea:https://doaj.org/article/4f90bdf6a4af41ef87c8b171f0e83055
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4f90bdf6a4af41ef87c8b171f0e83055
record_format dspace
spelling oai:doaj.org-article:4f90bdf6a4af41ef87c8b171f0e830552021-12-02T12:33:00ZInhibition of poly-LacNAc biosynthesis with release of CMP-Neu5Ac feedback inhibition increases the sialylation of recombinant EPO produced in CHO cells10.1038/s41598-018-25580-92045-2322https://doaj.org/article/4f90bdf6a4af41ef87c8b171f0e830552018-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-25580-9https://doaj.org/toc/2045-2322Abstract Sialylation of recombinant therapeutic glycoproteins modulates their pharmacokinetic properties by affecting their in vivo half-life. N-glycan branching on glycoproteins increases the number of potential attachment sites for sialic acid. Here, we introduce a new approach for increasing the sialylation of recombinant human erythropoietin (rhEPO) produced in CHO cells by modulating poly-N-acetyllactosamine (poly-LacNAc) biosynthesis. We did not observe an increase in rhEPO sialylation, however, until the feedback inhibition by intracellular cytidine monophosphate-N-acetylneuraminic acid (CMP-Neu5Ac), which is a limiting factor for sialylation, was released. Thus, we found that a combined approach inhibiting poly-LacNAc biosynthesis and releasing CMP-Neu5Ac feedback inhibition produces the most significant increase in rhEPO sialylation in metabolically engineered CHO cells. Furthermore, a detailed analysis of the resulting N-glycan structures using LC/MS revealed increased tri- and tetra- sialylated N-glycan structures accompanied by a reduction of di-sialylated N-glycan structures. These results validate our new approach for glycosylation engineering, and we expect this approach will be useful in future efforts to enhance the efficacy of other therapeutic glycoproteins.Chung-Geun LeeMyung Jin OhSeung-Yeol ParkHyun Joo AnJung Hoe KimNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-9 (2018)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Chung-Geun Lee
Myung Jin Oh
Seung-Yeol Park
Hyun Joo An
Jung Hoe Kim
Inhibition of poly-LacNAc biosynthesis with release of CMP-Neu5Ac feedback inhibition increases the sialylation of recombinant EPO produced in CHO cells
description Abstract Sialylation of recombinant therapeutic glycoproteins modulates their pharmacokinetic properties by affecting their in vivo half-life. N-glycan branching on glycoproteins increases the number of potential attachment sites for sialic acid. Here, we introduce a new approach for increasing the sialylation of recombinant human erythropoietin (rhEPO) produced in CHO cells by modulating poly-N-acetyllactosamine (poly-LacNAc) biosynthesis. We did not observe an increase in rhEPO sialylation, however, until the feedback inhibition by intracellular cytidine monophosphate-N-acetylneuraminic acid (CMP-Neu5Ac), which is a limiting factor for sialylation, was released. Thus, we found that a combined approach inhibiting poly-LacNAc biosynthesis and releasing CMP-Neu5Ac feedback inhibition produces the most significant increase in rhEPO sialylation in metabolically engineered CHO cells. Furthermore, a detailed analysis of the resulting N-glycan structures using LC/MS revealed increased tri- and tetra- sialylated N-glycan structures accompanied by a reduction of di-sialylated N-glycan structures. These results validate our new approach for glycosylation engineering, and we expect this approach will be useful in future efforts to enhance the efficacy of other therapeutic glycoproteins.
format article
author Chung-Geun Lee
Myung Jin Oh
Seung-Yeol Park
Hyun Joo An
Jung Hoe Kim
author_facet Chung-Geun Lee
Myung Jin Oh
Seung-Yeol Park
Hyun Joo An
Jung Hoe Kim
author_sort Chung-Geun Lee
title Inhibition of poly-LacNAc biosynthesis with release of CMP-Neu5Ac feedback inhibition increases the sialylation of recombinant EPO produced in CHO cells
title_short Inhibition of poly-LacNAc biosynthesis with release of CMP-Neu5Ac feedback inhibition increases the sialylation of recombinant EPO produced in CHO cells
title_full Inhibition of poly-LacNAc biosynthesis with release of CMP-Neu5Ac feedback inhibition increases the sialylation of recombinant EPO produced in CHO cells
title_fullStr Inhibition of poly-LacNAc biosynthesis with release of CMP-Neu5Ac feedback inhibition increases the sialylation of recombinant EPO produced in CHO cells
title_full_unstemmed Inhibition of poly-LacNAc biosynthesis with release of CMP-Neu5Ac feedback inhibition increases the sialylation of recombinant EPO produced in CHO cells
title_sort inhibition of poly-lacnac biosynthesis with release of cmp-neu5ac feedback inhibition increases the sialylation of recombinant epo produced in cho cells
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/4f90bdf6a4af41ef87c8b171f0e83055
work_keys_str_mv AT chunggeunlee inhibitionofpolylacnacbiosynthesiswithreleaseofcmpneu5acfeedbackinhibitionincreasesthesialylationofrecombinantepoproducedinchocells
AT myungjinoh inhibitionofpolylacnacbiosynthesiswithreleaseofcmpneu5acfeedbackinhibitionincreasesthesialylationofrecombinantepoproducedinchocells
AT seungyeolpark inhibitionofpolylacnacbiosynthesiswithreleaseofcmpneu5acfeedbackinhibitionincreasesthesialylationofrecombinantepoproducedinchocells
AT hyunjooan inhibitionofpolylacnacbiosynthesiswithreleaseofcmpneu5acfeedbackinhibitionincreasesthesialylationofrecombinantepoproducedinchocells
AT junghoekim inhibitionofpolylacnacbiosynthesiswithreleaseofcmpneu5acfeedbackinhibitionincreasesthesialylationofrecombinantepoproducedinchocells
_version_ 1718393917924179968